Page results
-
This information aims to support and supplement the information provided in the Be Active video available on uclh.nhs.uk/wellbeing
-
This is information for women who have been given a diagnosis of adenomyosis.
-
This service provides a tertiary level, second opinion service, specialising in the diagnostic assessment and treatment of complex speech sound disorders. The team has particular expertise in Childhood Apraxia of Speech (CAS).
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
-
Bones marrow harvest patient information page.
-
Information about the Integrative Talking Therapies service at the Royal London Hospital for Integrated Medicine.
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
This page provides information about ERCP (Endoscopic Retrograde Cholangiopancreatography) procedure.
-
The Neuroimmunology and CSF Laboratory at the Institute of Neurology, UCLH is a UKAS accredited medical laboratory No. 8045.
File results
-
FOI/2023/0736 - Placements in locked rehabilitation for adults with mental health diagnosis
-
FOI/2023/0737 - Cancelled appointments at maternity unit from December 2022
-
FOI/2023/0738 - Patients treated with Biologic medicines in gastroenterology
-
FOI/2023/0741 - Anaesthesia Associates staff
-
FOI/2023/0742 - Cancer treatments
-
FOI/2023/0751 - Patient numbers and drug spend for Waldenstrom's Macroglobulinaemia
-
FOI/2023/0752 - Cancer patient deaths whilst on waiting list
-
FOI/2023/0753 - Drug-related admissions in A&E 2018-2023
-
FOI/2023/0756 - Physician Associates and Anaesthesia Associates staff
-
FOI/2023/0761 - Trust EPR system/ clinical data repository